BTIG terminates sales agreement with Matinas Biopharma
Matinas BioPharma Holdings Inc MTNB.A said BTIG terminates its sales agreement with Matinas Biopharma Holdings, effective immediately on July 23, 2026, according to an SEC filing.
Matinas BioPharma said it incurs no termination penalties or expenses from the sales agreement termination, according to the SEC filing.
MTNB•
